Streetbeat News

Earnings

CIVB

Civista Bancshares (NASDAQ:CIVB) reported Q1 2024 earnings of $0.41 per share, missing the $0.46 estimate, and sales of $36.876M, below the $38.328M estimate. This represents a 50% decrease in earnings and a 15.56% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:35 pm

SPGC

Sacks Parente Golf (NASDAQ:SPGC) reported Q1 EPS of $(0.08), unchanged YoY, with sales increasing to $350K from $90K, a 288.89% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:34 pm

SPY

The Employment Cost Index for Q1 showed a +1.2% increase, surpassing the estimated +1%.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:30 pm

NRBO

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) announced its cardiometabolic assets, DA-1241 and DA-1726, will be presented at the EASL Congress 2024 and the ADA 84th Scientific Sessions in June. DA-1241 has completed enrollment for Part 1 of its Phase 2a clinical trial for MASH treatment, and DA-1726 has begun its Phase 1 trial for obesity treatment. Top-line data for DA-1726 is expected in Q3 2024 and Q1 2025. The presentations highlight the pre-clinical data's recognition and the progress of both programs.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:28 pm

ACRHF

Acreage Holdings, Inc. reported a YoY decline in quarterly and yearly revenue for Q4 and full year 2023, with revenues of $52.8 million and $223.4 million respectively. Despite the revenue decline, the net loss decreased significantly. The company completed strategic initiatives, including the expansion of its Egg Harbor facility and upgrading cultivation capabilities in Illinois. Acreage is preparing for acquisition by Canopy USA, focusing on high-margin products and flagship brands.

Portfolio Pulse from Nina Zdinjak

April 30, 2024 | 12:26 pm

IMAX

PSMT

RJF

WMT

Insiders at Walmart, IMAX, PriceSmart, and Raymond James Financial have recently sold shares. These sales could indicate various sentiments about the companies' prospects. Walmart's CEO sold shares after a price target adjustment. IMAX's CTO sold shares following an earnings beat. PriceSmart's director sold shares after announcing a special dividend. Raymond James Financial's CEO sold shares after mixed financial results.

Portfolio Pulse from Avi Kapoor

April 30, 2024 | 12:25 pm

LCNB

LCNB Corp reported Q1 adjusted earnings of $0.20 per share, missing the consensus estimate of $0.36 by 44.44%. This represents a 45.95% decrease from the $0.37 per share earned in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:23 pm

AMD

SOXX

Advanced Micro Devices, Inc. (NASDAQ:AMD) is set to report its Q1 earnings, with expectations of a modest year-over-year increase in earnings and revenue, driven by its AI technology and products like the MI300 AI accelerator and EPYC CPUs. Despite a global decline in PC shipments, analysts remain optimistic about AMD's performance, particularly in its Data Center and Server Compute businesses. Rival Intel's recent earnings miss and AMD's premarket stock increase suggest heightened interest in AMD's financial health and future outlook. The company's stock has seen significant growth year-to-date, outperforming the broader semiconductor market represented by the iShares Semiconductor ETF (NASDAQ:SOXX).

Portfolio Pulse from Shanthi Rexaline

April 30, 2024 | 12:22 pm

AKLI

Akili, Inc. (NASDAQ:AKLI) has amended its agreement with Shionogi, resulting in the cancellation and forgiveness of a $5M debt and the receipt of near-term cash payments totaling up to $18M for SDT-001, a digital ADHD treatment. Additionally, Akili is exploring strategic alternatives to maximize shareholder value, which includes a significant workforce reduction by 46% and a reduction in promotional activities. The company also plans to release its Q1 2024 financial results on May 14, 2024, without hosting an earnings call.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:21 pm

NXRT

NexPoint Residential (NXRT) reported Q1 2024 FFO of $0.75 per share, surpassing the $0.68 estimate. However, their sales of $67.600 million missed the $66.579 million estimate, marking a 100% decrease from $69.200 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 30, 2024 | 12:18 pm